NCT03443791View on ClinicalTrials.gov

Cytomegalovirus (CMV) Vaccines: Reinfection and Antigenic Variation

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions
Cmv CongenitalCMV Viremia
Interventions
DIAGNOSTIC_TEST

Women Enrolled

Diagnostic Testing will be performed. Results of individual test results will determine the degree of intervention offered.

DIAGNOSTIC_TEST

Newborns of Female Study Participants

Newborns will be tested after birth as soon as possible for CMV positivity.

Trial Locations (1)

Unknown

RECRUITING

University of Sao Paulo, São Paulo

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER